Background: Yellow fever virus (YFV) is an RNA virus maintained in an enzootic, sylvatic cycle involving nonhuman primates (NHPs) and sylvatic mosquito vectors primarily of the genus Haemagogus and Sabethes. Transmission occasionally spills over to humans entering forested regions. In the Americas, urban transmission of YFV to humans has not occurred since the mid-1900s because of vaccination and near-elimination of the anthropophilic Aedes aegypti, the urban vector (1). However, concerns about reemergence of urban YFV have recently increased because of the reappearance and rapid spread of A aegypti in the urban environment. Furthermore, immunization coverage for YFV is insufficient because vaccination is generally indicated only for higher-risk populations, such as those living in or travelling to areas with sylvatic transmission.
No takes yet. Share an insight, caveat, or question.
Paploski et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: